Listen

And the Beat Goes On: Improving Heart Failure and Chronic Kidney Disease Outcomes with SGLT2 Inhibitors

Cardiovascular-kidney-metabolic (CKM) syndrome is the multidirectional relationship between cardiovascular diseases such as heart failure (HF), chronic kidney disease (CKD), and metabolic conditions such as type 2 diabetes (T2D), which can lead to adverse outcomes including premature death, premature morbidity, multiorgan dysfunction, cardiovascular events, decreased quality of life, and excessive medical expenses. Given the relationship between these diseases, SGLT2 inhibitors have expanded indications beyond T2D and now have substantial evidence supporting their use throughout CKM syndrome, including CKD with and without T2D and/or HF throughout the full ejection fraction spectrum. However, adverse social determinants of health, siloed healthcare, lack of understanding CKM syndrome, clinical inertia, lack of knowledge of new SGLT2 inhibitor indications, and changing guidelines serve as barriers to patient-centered treatment.

This educational activity will include evidence-based care and best practices for identifying and addressing barriers and social determinates of health that impact CKM syndrome. Methods to incorporate multidisciplinary collaboration into various care settings to support holistic, patient-centered care will be discussed. This activity will apply current guideline recommendations for early identification, screening, and treatment of patients with SGLT2 inhibitors in chronic kidney disease and heart failure. The latest evidence focused on the use of SGLT2 inhibitors on cardiovascular and kidney outcomes will be discussed and applied to individualized patient cases.

Monday, Dec. 8
11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Symposium Location: Islander Ballroom F, Lower Level, Mandalay Bay North Convention Center

Come early! Seating is limited and provided on a first-come, first-served basis.

Can't make it to Las Vegas? Tune into the Free Live Webinar Broadcast.
Registration is required for the webinar.

Webinar Registration

Speakers

Leo F. Buckley, PharmD, MPH, BCCP, Activity Chair
Assistant Professor, Division of Cardiology – University of Texas Southwestern Medical Center
Assistant Professor, Department of Epidemiology – UT Southwestern Peter O’Donnell School of Public Health
Dallas, Texas

Leo F. Buckley is an Assistant Professor in the Department of Internal Medicine (Cardiology) at the University of Texas Southwestern Medical Center and in the Department of Epidemiology at the UT Southwestern O’Donnell School of Public Health, both in Dallas, Texas. After graduating from Northeastern University's School of Pharmacy, he completed residencies in Pharmacy Practice and Cardiovascular Pharmacotherapy at Brigham and Women's Hospital and a research fellowship at Virginia Commonwealth University. At UT Southwestern, he leads a cardiovascular pharmacology research program and practices as a clinical pharmacist. His clinical and research interests include cardio-renal inflammation and metabolism.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Diabetes Care and Education Specialist and Consultant – Bolingbrook Christian Health Center and Will Grundy Medical Clinic
Professor Emeritus – Midwestern University College of Pharmacy Downers Grove, IL
Orland Park, Illinois

Susan Cornell, PharmD is the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Grove, Illinois. Dr. Cornell is also a clinical pharmacist and certified diabetes care and education specialist with the Bolingbrook Christian Health Center, where she trains, educates, and supervises students from the colleges of medicine, pharmacy, and health sciences, as they provide medication therapy management and diabetes care and education for underserved populations. Dr. Cornell served as President of the Illinois Pharmacists Association in 2011. She has received numerous awards and recognitions, including the 2022 Allene Von Son Distinguished Service Award, the 2021, 2019 and 2011 Outstanding Faculty Advisor, 2017 Outstanding Illinois Diabetes Educator of the Year, 2014 Bowl of Hygeia, to list a few. She is an active member of the American Diabetes Association. She is also actively involved with the Association of Diabetes Care and Education Specialists, where she served on their board of directors from 2004 to 2007 and continues to assist on various committees. Dr. Cornell has been invited to give numerous presentations to various healthcare professionals and community groups worldwide. She has served as editor, as well as, published and contributed to many peer-reviewed, professional written and online publications. Dr. Cornell served as an associate editor of the ADCES Art and Science of Diabetes Care and Education Desk Reference- 3rd thru 6th edition.

Target Audience

The target audience for this education is pharmacists who practice in hospitals, health systems, community pharmacies, and ambulatory clinics who care for or are interested in the care of patients with heart failure (full spectrum of ejection fraction) and/or chronic kidney disease (with or without diabetes).

Learning Objectives

Analyze the pathophysiology of CKM syndrome and its application to early identification, appropriate screening, and staging.
Identify methods for providing holistic, person-centered care through addressing individualized SDOH barriers and providing interprofessional care to people with cardiovascular-kidney-metabolic comorbidities.
Apply current clinical practice guidelines for the treatment of people with HF throughout the full spectrum of ejection fraction range and/or CKD with or without diabetes.

Agenda

11:30 a.m. – Welcome and Introductions
Leo F. Buckley
11:35 a.m. – Early Identification of CKD and HF in CKM Syndrome
Leo F. Buckley
12:05 p.m. – Incorporating SDOH into Individualized CKM Syndrome Treatment and Management
Susan Cornell
12:30 p.m. – Cased-Based Examples of Using SGLT2 Inhibitors in CKD and HF
All Faculty
12:50 p.m. – Faculty Discussion, Questions and Answers
All Faculty

Accredited for CPE

ACPE #: 0204-0000-25-408-L01-P
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.